Advances in Immunology: Allergy and allergic diseases: Second of two parts

New England Journal of Medicine

Volumn 344, Issue 2, 2001, Pages 109-113

  Mackay, I R ^a   Rosen, F S ^a   Kay, A B ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CETIRIZINE; CHITOSAN; CORTICOSTEROID; CYCLOSPORIN; DNA VACCINE; FEXOFENADINE; LORATADINE; MONOCLONAL ANTIBODY; PLASMID VECTOR; TACROLIMUS;

ALLERGIC DISEASE; ALLERGIC RHINITIS; ALLERGY; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ASTHMA; ATOPIC DERMATITIS; ECZEMA; IMMUNOTHERAPY; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; URTICARIA; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; RHINITIS;

ANAPHYLAXIS; ASTHMA; DERMATITIS, ATOPIC; HUMANS; HYPERSENSITIVITY; IMMUNOTHERAPY; RHINITIS; URTICARIA; VACCINES, DNA;

EID: 0035843316     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200101113440206     Document Type: Review

References (33)

1. Second-generation antihistamines: A comparative review
2. Long-term clinical efficacy of grass-pollen immunotherapy
3. Immunologic changes associated with allergen immunotherapy
4. Nasal challenge with ragweed pollen in hay fever patients: Effect of immunotherapy
5. Grass pollen immunotherapy decreases the number of mast cells in the skin
6. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses
7. Role of interleukin 10 in specific immunotherapy
8. IL-10: Evolving concepts
9. The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: More similarities than differences
10. Identification and mutational analysis of the immunodominant IgE binding epitopes of the major peanut allergen Ara h 2
11. Oral gene delivery with chitosan - DNA nanoparticles generate immunologic protection in a murine model of peanut allergy
12. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis
13. The immunopathogenic role of food hypersensitivity in atopic dermatitis
14. Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis
15. Recent therapeutic advances in dermatology
16. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria
17. Chronic idiopathic urticaria: Comparison of the clinical features of patients with and without anti-FcεRI or anti-IgE autoantibodies
18. Plasmapheresis for severe, unremitting, chronic urticaria
19. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: Potential use of hypoallergenic isoforms for immunotherapy
20. Four recombinant isoforms of Cor a I, the major allergen of hazel pollen, show different IgE-binding properties
21. Treatment of cat allergy with T-cell reactive peptides
22. HLA-DR restricted peptide candidates for bee venom immunotherapy
23. Gene vaccination: Plasmid DNA is more than just a blueprint
24. Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization
25. Down-regulation of FcεRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody
26. Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis
27. Treatment of allergic asthma with monoclonal anti-IgE antibody
28. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects
29. Interleukin-4 receptor in moderate atopic asthma: A phase I/II randomized, placebo-controlled trial
30. Interleukin-4 and its receptor: Essential mediators of the allergic response
31. Effects of an antibody to interleukin-5 in a monkey model of asthma
32. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response
33. Chemokine receptor usage by human eosinophils: The importance of CCR3 demonstrated using an antagonistic monoclonal antibody